Rectum adenocarcinoma

The development of colorectal cancer begins in the glandular cells. The disease can affect any organ, since metastases subsequently affect other glandular tissues. Adenocarcinoma of the rectum is most common in people older than fifty years. The main causes of the disease are malnutrition, bad habits and papillomavirus infection .

Types of disease

The presence of these or other diagnostic materials will allow us to analyze the degree of development of the disease. Later, on the basis of this, the doctor will prescribe appropriate treatment.

Depending on the differentiation, these forms of the disease are distinguished:

1. Low-grade adenocarcinoma of the rectum. It is difficult to attribute to a specific tissue, while the tumor of the rectum has the highest malignancy, is accompanied by metastases and is characterized by a disappointing prognosis.
2. Moderately differentiated adenocarcinoma of the rectum. This form is a tumor, the tissues of which are difficult to correlate with the tissues of the rectum, therefore the diagnosis is difficult to make.
3. Highly differentiated adenocarcinoma of the rectum. Tumor cells with their structure resemble affected tissues of the rectum. This allows you to quickly identify the disease, which increases the chances of recovery.
4. Undifferentiated cancer. This form is characterized by a proliferation of education and complexity in the treatment.

Treatment of rectal adenocarcinoma

The main method of treatment is surgical intervention. However, it is only possible with the patient's consent. During the operation, the tumor itself is removed and the adjacent tissues are located nearby.

But most often resort to complex treatment, which includes the impact on the tumor (in order to reduce it) and subsequent removal. Reductions in size are achieved by radio irradiation, which reduces the number of dangerous cells.

Prognosis for rectal adenocarcinoma

The success of treatment depends on the stage of the disease. Survival in five years is observed in 90% of patients. In the advanced stages with the presence of metastases in the lymph nodes, only half of the patients survive after five years. After the transplantation of the operation, patients must be regularly observed to detect relapse and metastasis in time.

With the timely detection of relapse, surgery can be performed only in 34% of patients, because the rest have a bad chance of survival. Therefore, only chemotherapy and radio irradiation can be prescribed to them.